Viemed Healthcare, Inc.
NASDAQViemed Healthcare walked into its Q1 2026 earnings print carrying a 3.5% weekly loss and walked out with a 2.3% bounce — a tidy illustration of how much was already priced for caution before the numbers dropped. Q1 results split neatly between a revenue beat and an earnings miss. Sales came in at $75.4 million, up 28% year-over-year and ahead of the $74.4 million consensus. EPS of…
Snapshot as of 9 May 2026
Viemed Healthcare walked into its Q1 2026 earnings print carrying a 3.5% weekly loss and walked out with a 2.3% bounce — a tidy illustration of how much was already priced for caution before the numbers dropped. Q1…
VMD Misses on EPS but Lifts Guidance Viemed Healthcare walked into its Q1 2026 print with a clean lending market but a narrative already complicated by insider selling — and the numbers delivered a familiar split…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VMD — free to start on ORTEX.
Sign up for free →Open VMD on ORTEX